Pancreatitis, Type 2 Diabetes Mellitus, and Pancreatic Cancer (Diabetes Metab J 2025;49:252-63).
0/5 보강
APA
Lai SW, Liao KF (2025). Pancreatitis, Type 2 Diabetes Mellitus, and Pancreatic Cancer (Diabetes Metab J 2025;49:252-63).. Diabetes & metabolism journal, 49(3), 518-519. https://doi.org/10.4093/dmj.2025.0237
MLA
Lai SW, et al.. "Pancreatitis, Type 2 Diabetes Mellitus, and Pancreatic Cancer (Diabetes Metab J 2025;49:252-63).." Diabetes & metabolism journal, vol. 49, no. 3, 2025, pp. 518-519.
PMID
40367995 ↗
같은 제1저자의 인용 많은 논문 (5)
- Lipid‑Lowering Agents and Hepatocellular Carcinoma Risk.
- Comment on "Lower glycemic status was associated with pancreatic cancer risk in prediabetes".
- Antrocinol-mediated downregulation of ATG5 induces autophagy-dependent cell death and activates the unfolded protein response through PERK/CHOP signaling in lenvatinib-resistant hepatocellular carcinoma cells.
- New-onset diabetes mellitus and the risk of pancreatic cancer.
- Calcium Channel Blocker and Hepatocellular Carcinoma Risk.